WM: 2023 update on diagnosis, risk stratification, and management
Gertz MA
Am J Hematol · 2023
Key Findings
- ●Comprehensive annual update on WM management
- ●Updated treatment algorithms incorporating BTK inhibitors
- ●Discussion of emerging agents and combination strategies
Referenced in (1 disease)
Validation history
Full log →No validation events recorded yet. Source will be checked on the next kipine-source-validator run.
ID: pmid-36588395DOI: 10.1002/ajh.26796PMID: 36588395